OZEM vs THNR: Holdings Overlap & Returns

Over the year to Nov 13, 2026, OZEM returned +0.7% to THNR's +6.7%; 64% of their weight is in the same names.

Return gap
+6.0 pts1 year to Nov 13, 2026: THNR ahead, total return
Fee gap
0.00 ptsA year: both 0.59%, per filings dated Jan 28, 2026 and Apr 30, 2026
Overlap
64%Share of the two books held in common, holdings dated Nov 13, 2026
Net flow
−$1m / −$791kOZEM / THNR, Oct 13, 2026 to Nov 12, 2026, daily basis
The answerOne drawing that carries it.

Compare two other funds

The evidenceWhy, in charts and cards.
OZEM and THNR · 1 year

Growth of 100

OZEM +0.7%THNR +6.7%
Growth of 100 in OZEM and THNR over 1 year, Nov 13, 2025 to Nov 13, 2026, with distributions reinvested. OZEM ends at 100.7 (+0.7%), THNR at 106.7 (+6.7%).

OZEM +0.7%, THNR +6.7%: THNR +6.0 pts ahead, 1 year, Nov 13, 2025 to Nov 13, 2026.

Share

Use this comparison

Alert

OZEM and THNR flows, by email on Sundays.

One-click unsubscribe. See Privacy.

Hypothetical · drag the order size

Cost to trade

Hypothetical. A $10,000 order in THNR costs about $14.00 one way and $28.00 in and out, at a median spread of 0.28%. The 0.28% spread is THNR’s 30-day median, from Amplify (fund page).

Hypothetical · drag to set

Fees over time

Hypothetical. $10,000 in OZEM for 10 years at 0.59% a year costs about $972 in fees and lost growth; THNR at 0.59% would cost $972. Assumes 6% a year before fees, a sample rate, not a forecast.

How each fund moved

OZEM · 1 year to Nov 13, 202670% of its weight is outside the S&P 500
70% of its weight is outside the S&P 50030% of OZEM's weight is in S&P 500 companies and 70% is outside the index. Holdings as of Nov 13, 2026.30%70%in the S&P 500of its weight outside the S&P 500active share 98% · top ten 72% of the fund · 21 holdings as published by its issuer for Nov 13, 2026 · Nasdaq-100: 4% in70% of its weight is outside the S&P 50030% of OZEM's weight is in S&P 500 companies and 70% is outside the index. Holdings as of Nov 13, 2026.30%70%inoutside the S&P 500active share 98% · Nasdaq-100: 4% in

30% of OZEM's weight is in S&P 500 companies and 70% is outside the index. Holdings as of Nov 13, 2026.

THNR · 1 year to Nov 13, 202654% of its weight is outside the S&P 500
54% of its weight is outside the S&P 50046% of THNR's weight is in S&P 500 companies and 54% is outside the index. Holdings as of Nov 13, 2026.46%54%of its weight in S&P 500 companiesof its weight outside the S&P 500active share 97% · top ten 66% of the fund · 21 holdings as published by its issuer for Nov 13, 2026 · Nasdaq-100: 18% in54% of its weight is outside the S&P 50046% of THNR's weight is in S&P 500 companies and 54% is outside the index. Holdings as of Nov 13, 2026.46%54%in the S&P 500outside the S&P 500active share 97% · Nasdaq-100: 18% in

46% of THNR's weight is in S&P 500 companies and 54% is outside the index. Holdings as of Nov 13, 2026.

Key numbers

OZEM in the S&P 500
30.4%
THNR in the S&P 500
45.8%
OZEM total return, 1 year
+0.7%
THNR total return, 1 year
+6.7%

Both cost 0.59% a year; their one-year returns differ by 6.0 points; OZEM is 11.0 times larger.

Pair scorecard

Open the table

Points (pts) are percentage points.

Total return, 1 year+0.7%+6.7%
Below its all-time high15.1%, high on Jan 26, 20266.3%, high on Aug 25, 2026
What it tracksHealthcare innovation and GLP-1Healthcare innovation and GLP-1
Expense ratio0.59%0.59%
Net assets, as of Nov 12, 2026$57m$5.2m
Active share vs the S&P 50098%96%
Holdings in common64%

The numbers behind it

Net assets: $57m on Nov 13, 2026 for Roundhill GLP-1 & Weight Loss ETF, and $5.2m on Nov 12, 2026 for Amplify Weight Loss Drug & Treatment ETF.

Holdings in common uses holdings dated Nov 13, 2026.

What they share

By the books each fund has filed, OZEM and THNR hold 64% of their money in the same securities at the same weight. Holdings dated Nov 13, 2026.

0half (50%)100%

half

64% in common

Held in common

Show all 12 holdings
Eli Lilly & Co20.30%12.10%
Novo Nordisk A/S10.86%8.89%
Pfizer Inc5.69%5.24%
Chugai Pharmaceutical Co Ltd6.82%5.17%
CSPC Pharmaceutical Group Ltd4.56%4.44%
Viking Therapeutics Inc3.94%4.43%
AstraZeneca PLC3.22%5.79%
Hanmi Pharm Co Ltd6.97%3.19%
Zealand Pharma A/S3.12%3.29%
Amgen Inc2.99%6.11%
Roche Holding AG2.70%5.68%
Jiangsu Hengrui Pharmaceuticals Co Ltd4.16%2.27%

Only in OZEM

Show all 5 holdings
Hansoh Pharmaceutical Group Co Ltd3.77%
Ascletis Pharma Inc3.36%
Gubra A/S2.14%
United Laboratories International Holdings Ltd2.03%
MBX Biosciences Inc1.75%

Only in THNR

Show all 5 holdings
Regeneron Pharmaceuticals Inc6.05%
AbbVie Inc5.65%
Merck & Co Inc4.98%
Arrowhead Pharmaceuticals Inc2.81%
Invesco Government & Agency Portfolio 12/31/20310.47%

Side by side

Open the table
FundRoundhill GLP-1 & Weight Loss ETF · Holds 21 stocks in healthcare innovation and GLP-1, 30% of its weight in S&P 500 companiesAmplify Weight Loss Drug & Treatment ETF · Holds 21 stocks in healthcare innovation and GLP-1, 46% of its weight in S&P 500 companies
IssuerRoundhillAmplify
ThemeHealthcare innovation and GLP-1Healthcare innovation and GLP-1
In the S&P 50030.4%45.8%
Active share vs the S&P 50097.8%96.5%
In the Nasdaq-1004.4%17.8%
Holdings2121
Top ten, share of the fund72.0%66.3%
Expense ratio0.59%0.59%
Fee for the differing part0.60%0.61%
Total return, 1 year+0.7%+6.7%
vs its benchmarknot measurednot measured
Below its high−15.1%−6.3%
Net assets, OZEM as of Nov 13, 2026 and THNR as of Nov 12, 2026$57m$5.2m

As of Nov 13, 2026. Source: ETFIQ.

Window by window

Open the table
3 months−4.9%−0.1%
6 months+1.8%+7.0%
1 year+0.7%+6.7%
Since launch (OZEM May 2024 · THNR May 2024)+25.6%+5.6%

About OZEM

By weight, 30% of OZEM's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 72% of the fund across 21 positions, as published by its issuer for Nov 13, 2026.

More

Over the year to Nov 13, 2026 the fund returned +0.7% with distributions reinvested. It sits 15.1% below its all-time high of Jan 26, 2026.

About THNR

By weight, 46% of THNR's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 96%. The top ten holdings are 66% of the fund across 21 positions, as published by its issuer for Nov 13, 2026.

More

Over the year to Nov 13, 2026 the fund returned +6.7% with distributions reinvested. It sits 6.3% below its all-time high of Aug 25, 2026.

64% of the two portfolios are the same securities at the same weight.

Questions people ask

Do OZEM and THNR hold the same stocks?

By their latest filings, 64% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.

Which is more different from the S&P 500, OZEM or THNR?

OZEM has 30% of its weight in S&P 500 names and THNR has 46%, so OZEM differs more from the index.

Which is cheaper, OZEM or THNR?

OZEM and THNR both charge 0.59% a year, so neither is cheaper. Fees come from each fund's prospectus.

Other comparisons

Sources

More

Links are sources, not endorsements. A comparison is not a recommendation.

Copy and cite

Cite this pageCitation, APA and Markdown

ETFIQ, OZEM against THNR, data as of Nov 13, 2026. https://etfiq.com/compare/themes/ozem-vs-thnr

Open data

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.